Fig. 1From: Comparing proton pump inhibitors with histamin-2 receptor blockers regarding the risk of osteoporotic fractures: a nested case-control study of more than 350,000 Korean patients with GERD and peptic ulcer diseaseFlowchart of patient selection. PPI, proton pump inhibitor; H2RA, histamine-2 receptor antagonistBack to article page